If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
311.60    6.80 (2.23%)
Bid:
311.80
Ask:
312.20
Spread: 0.40 (0.128%)
Market Cap: £1.08b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Director/PDMR Shareholding

21 Nov 2025 07:00

RNS Number : 4445I
Breedon Group PLC
21 November 2025
 

 

 

 

LEI: 213800DQGNQE3X76WS92

 

21 November 2025

 

BREEDON GROUP plc

(the Company)

 

Director / PDMR Dealings

 

The Company has been notified that on 20 November 2025 Clive Watson, Non-executive Director of Breedon Group plc and a Person Discharging Managerial Responsibilities (PDMR), bought 7,456 shares of £0.01 each in the Company (Ordinary Shares), at a price of £3.1692 per Ordinary Share.

 

This notification is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

 

Enquiries:

 

Breedon Group plc www.breedongroup.com 

James Atherton-Ham, Company Secretary +44 (0)1332 694010

Louise Turner-Smith, Head of Investor Relations +44 (0)7860 911909

 

 

MHP (Public Relations Adviser) +44 (0)7770 753 544

Reg Hoare, Rachel Farrington, Charles Hirst breedon@mhpgroup.com

 

Notification and public disclosure of transactions by persons discharging managerial

responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Watson

2

Reason for the notification

a)

Position/status

Non-executive Director and PDMR

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800DQGNQE3X76WS92

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.01 each

 

GB00BM8NFJ84

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£3.1692 per share

7,456

d)

 

Aggregated information (if any)

 

- Aggregated volume

 

- Price

e)

Date of transaction

2025-11-20

f)

Place of the transaction

London Stock Exchange, XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFEFFASEISEEF
Date   Source Headline
7th Jul 20217:00 amRNSBlock listing Update
1st Jul 20216:16 pmRNSTotal Voting Rights
1st Jun 20213:49 pmRNSStandard form for notification of major holdings
1st Jun 20217:00 amRNSAcquisition
28th May 202110:02 amRNSTotal Voting Rights
7th May 20219:28 amRNSStandard form for notification of major holdings
23rd Apr 20211:46 pmRNSDirectors’ and PDMRs’ Dealings
23rd Apr 20211:37 pmRNSPDMR Dealings
20th Apr 20212:36 pmRNSResult of AGM
20th Apr 20217:00 amRNSAGM Trading Update
1st Apr 202111:04 amRNSGrant of SAYE Options and PDMR Dealings
1st Apr 20217:00 amRNSBoard Update
23rd Mar 202111:13 amRNSDirector Dealings
23rd Mar 202111:09 amRNS2020 Annual Report and Notice of AGM
10th Mar 20217:01 amRNSDirectorate Change
10th Mar 20217:00 amRNSAnnual Results 2020
26th Feb 20219:15 amRNSTotal Voting Rights
22nd Jan 20211:55 pmRNSDirector/PDMR Shareholding
22nd Jan 20218:46 amRNSAdditional Block Listing of Ordinary Shares
13th Jan 20217:00 amRNSAppointment of Corporate Broker
7th Jan 20212:45 pmRNSBlock listing Interim Review
23rd Dec 20207:00 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSTrading Update
3rd Dec 20207:00 amRNSUpdate on CMA's Review of Completed Acquisition
2nd Dec 20203:55 pmRNSHolding(s) in Company
1st Dec 20204:50 pmRNSHolding(s) in Company
1st Dec 20207:10 amRNSUpdate on CMA's Review of Completed Acquisition
30th Nov 20201:31 pmRNSTotal Voting Rights
24th Nov 20204:55 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSDirectorate Change
18th Nov 20207:00 amRNSTrading Update
9th Nov 20207:00 amRNSAcquisition update
30th Oct 20207:00 amRNSTotal Voting Rights
6th Oct 20207:00 amRNSDirectorate Change
30th Sep 20207:00 amRNSTotal Voting Rights
17th Sep 20207:00 amRNSTrading Update
10th Sep 20207:13 amRNSCMA's Review of Completed Acquisition
7th Sep 202012:50 pmRNSGrant of SAYE Options and PDMR Dealings
27th Aug 20202:53 pmRNSDirectors' and PDMRs' Dealings
26th Aug 20207:14 amRNSCMA's Review of Proposed Acquisition
19th Aug 20205:30 pmRNSHolding(s) in Company
19th Aug 20205:30 pmRNSHolding(s) in Company
13th Aug 20204:09 pmRNSDirector and PDMR Dealings
3rd Aug 20207:00 amRNSCompletion of acquisition
31st Jul 20207:00 amRNSTotal Voting Rights
29th Jul 20207:00 amRNSHalf-year Report
8th Jul 20207:00 amRNSBlock listing Interim Review
6th Jul 202010:30 amRNSHolding(s) in Company
6th Jul 202010:30 amRNSHolding(s) in Company
19th Jun 20203:41 pmRNSDirector and PDMR Dealings & Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.